HHS awards additional $487 million to states for opioid response

Mar 22, 2019 - 02:26 PM
Department of Health and Human Services (HHS) Seal

The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 to help states and territories increase access to medication-assisted treatment for opioid use disorder and reduce opioid overdose deaths. 鈥淪trategies such as employing psychosocial supports, community recovery services and MAT using medicines approved by the [Food and Drug Administration] constitute the gold standard of treatment for opioid use disorders,鈥 said Assistant Secretary for Mental Health and Substance Use Elinore McCance-Katz, M.D. The 10 states with the highest overdose mortality rates received 15 percent of the funding. HHS expects to award another $933 million in state opioid response grants later this year as part of its , launched a year ago this week.

Related News Articles

Headline
FDA approves first-in-class non-opioid painkiller聽
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to鈥
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,鈥
Headline
AHA podcast: Thinking Outside the Box to Reduce Behavioral Health Stigma and Disparities聽
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to鈥
Headline
'Take Back Day' Oct. 28 to dispose safely of prescription drugs
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and鈥
Headline
Agencies target unapproved pharmaceutical products from India
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from鈥
Headline
AHA sends SUPPORT Act reauthorization recommendations to House committee鈥
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and鈥